Murine fetal thymus lobes isolated from both normal and scid/scid mice can be colonized by donor cells from either human bone marrow or human umbilical cord blood in vitro. Subsequent organ culture results in a transient production of a few CD4+ CD8+ (double-positive) cells and then the accumulation of CD4+ or CD8+ (single-positive) T cells. A significant number of immature T-cell intermediates (e.g., CD8I0W, CD3-/lOw cells) were present in early organ cultures, suggesting that these were progenitors of the mature CD3+/high single-positive T cells that dominated late cultures. Depletion of mature T cells from the donor-cell populations did not affect their ability to colonize thymus lobes. However, colonization depended on the presence of CD7+ progenitor T cells. Limiting dilution experiments using mature T-cell populations (human peripheral blood leukocytes, human bone marrow cells, and human ukfbilical cord blood cells) suggested that thymic organ culture supports the growth of progenitor T cells but does not support the growth of mature human T cells. Each of these donor populations produced single-positive populations with different CD4/CD8 ratios, suggesting that precursor cells from different sources differ qualitatively in their capacity to differentiate into T cells.
In recent years, much has been learned about the cellular interactions involved in murine T-cell ontogeny. The development of the human immune system is less clearly defined, and the signals that direct human T-cell tolerance and repertoire selection remain to be elucidated. Murine fetal thymus organ culture (FTOC) retains the architecture of the thymic microenvironment and can support the development of phenotypically and functionally mature murine T cells (1) (2) (3) . FTOC can be used to study the effects of specific antibodies (4, 5) , cytokines (6) , or cell types (7) on T-cell differentiation and repertoire selection. Human CD4-CD8-doublenegative (DN) thymocytes will differentiate into CD4+ CD8+ double-positive (DP) intermediate T cells, as well as small numbers of CD4+ single-positive (SP) and CD8+ SP phenotypically mature T cells when seeded into murine fetal thymus lobes (8, 9) .
Human umbilical cord blood (HUCB) is a rich source of hematopoietic progenitor cells, comparable to human bone marrow (HBM) (10) . We show here that both HUCB and HBM cells can colonize murine fetal thymus lobes and generate mature human T cells. These data suggest that HUCB cells should be a good candidate for human transplantation. The rapid development of many mature SP human T cells by both HBM and HUCB, compared to similar studies using human thymocytes as precursors (8, 9) , suggests that
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these sources of progenitor T cells differ significantly in their ability to generate human T cells.
MATERIALS AND METHODS
Human Tissues. HBM was obtained from cadaver vertebra body sections and used after cryopreservation in -0.6 ml of dimethyl sulfoxide medium. The cells were stored in liquid nitrogen and thawed as described (11) . Fresh HBM and human peripheral blood leukocytes (HPBLC) were obtained from healthy volunteers. HUCB samples were obtained from normal full-term vaginal deliveries at the University Medical Center, University of Arizona. Mononuclear cells were purified from HBM, HPBLC, and HUCB by Ficoll-Hypaque density gradient (Sigma) separation.
Mice. Timed pregnant C.B-17 scid/scid [severe combined immunodeficiency (SCID)] mice were obtained from L. Shultz (The Jackson Laboratory). Timed pregnant C3H/HeN, C3H/ HeJ, AKR/J, or C57BL/6 mice were from Simonsen Laboratories (Gilroy, CA) and The Jackson Laboratory.
Purification of Progenitor Cells. HBM was depleted of T cells, as described (12) . Antibody-plus-complement treatment of fresh HBM resulted in 63 ± 5.8% recovery of total cells with 78.5 ± 5.9% viability. Similar treatment of surgically resected HBM resulted in 64% recovery of total cells after Ficoll separation to remove dead cells. This tissue gave a 42-100% recovery of CFU-C and BFU-E progenitor cells but no functional T cells in 105 total cells (12) . T and B cells were removed from HUCB by panning with kits from Applied Immune Systems (Menlo Park, CA). CD4+ or CD8+ cells were <1% in all tissues by flow cytometry (FC). CD34+ and CD34+/CD7+ cells were isolated from nonadherent mononuclear HBM and HUCB cells by positive indirect adherence (panning) using anti-CD34 (13) and then anti-CD7 (Becton Dickinson Immunocytometry Systems).
FTOC. Seven to 10 thymus lobes dissected from 13-to 15-day gestation fetal mice were organ-cultured (1-4) in medium/20%o fetal bovine serum (HyClone). Thymuses were colonized with ::105-106 cells per lobe, by directly applying cell pellets to the lobes in 0.2-,ul aliquots. In some experiments, lobes were treated with 2-deoxyguanosine (dGuo, 1.35 mM) for 5 days at 37°C to deplete resident lymphocytes before reconstitution (7) . The cultures were grown in a fully humidified incubator and 5% C02/95% air at 37°C.
Cell-Yield Assessment. The cell yield from cultures was determined by placing lobes in collagenase at 0.4 mg/ml Development of HUCB cultures was explored further with three-color FC (Fig. 1) . Seven-day cultures were chosen because they had more immature T cells (see below). We detected several developmental intermediates in these early cultures, in addition to the bright CD4+ and CD8+ SP T cells, DP T cells, and DN T cells normally found in thymus. For example, 8.2% of cells recovered from 7-day cultures are CD8l0w ( Fig. 1, population II Depletion of mature T cells from HBM with anti-CD2, -CD3, -CD4, -CD5, and -CD8 did not affect its ability to generate CD2+ cells after 12 days in culture using dGuotreated recipient tissue (68.4 ± 6.8% with 2.5 x 104 CD2+ cells recovered per lobe). However, identical pretreatment that included anti-CD7 mAb abolished colonization of the thymus lobes (2.6 ± 2.6% with 0.25 x 104 CD2+ cells recovered per lobe). Similar results were found when CD4+ CD8+ cell production was analyzed (compare experiment 418, Table 2 , where CD7+ cells were depleted and experiment 454 where CD7+ cells were not depleted). In these latter experiments, the donor HBM was depleted by mAb and complement, resulting in HBM populations with <1% phenotypically mature T cells as analyzed by FC or <1/105 cells analyzed functionally (12) . Because human T-cell progenitors express the CD7 molecule (16) (Table 2) .
Finally, CD34+ cells and CD34+ CD7+ DP cells purified from HBM and HUCB could both develop into mature T cells, even when low doses were used. Thus, 7 x 103 HBM CD34+ CD7+ cells per lobe was sufficient to colonize SCID recipients, and a 10-times smaller number of HUCB CD34+ cells and HUCB CD34+ CD7+ cells than unfractionated HUCB could colonize B6 recipients (Table 3) 12-day cultures had the CD3 CD8+ phenotype (1.4 ± 0.5% of total cells). This subpopulation has been implicated as an early intermediate in murine T-cell development (17) . The frequency of CD3 CD8+ cells was much higher in 2-day cultures (13.8 ± 4.7%), and this value decreased progressively to 6.8 ± 3.2% at 5 days and 1.7 ± 0.5% by 10 days of culture. This result would be expected were the mature cells of late cultures derived from CD3-CD8+ cells. The progression from CD3-CD8+ cells to cells with mature phenotypes suggested that the mature cells at 12 days were derived from immature precursors that go through a CD4+ CD8+ DP stage. To determine whether a transitional DP phenotype exists in human/mouse chimeric FTOC, the growth kinetics of SCID lobes colonized with HUCB cells was investigated. Approximately 106 HUCB cells were seeded per lobe, and the human T-cell phenotype was determined various times after colonization. Fig. 3 shows an experiment in which DP thymocytes were present transiently at the beginning of organ culture, and these DP cells decreased in number as SP cells increased. These data suggest that development of DP cells in this system is rapid and transient, allowing for rapid development of SP cells.
DISCUSSION
Our results suggest that human T cells can rapidly develop into CD4+ or CD8+ SP cells expressing CD3 in murine FTOC when HBM or HUCB are donor tissues. Deliberate addition of many HPBLC to organ cultures did not increase the frequency of human T-cell precursors compared with HBM and HUCB. HBM and HUCB depleted of mature T cells still provided precursors for T-cell development in the organ culture system. The numbers of T-cell-depleted HBM cells used to colonize murine fetal thymus [ Table 2 ; <1/105 functional T cells for the BM(-2,5,n)-preparation] were also similar to that required for HPBLC, HUCB, and unfractionated HBM. Thus, mature T-cell contaminants in these tissues are probably not responsible for development of the mature cells recovered from these cultures. The ability of HBM to repopulate mouse thymus lobes also depended on CD7+ or CD7+ CD34+ lymphocyte progenitor cells (16) . Enrichment ofprogenitor-cell populations with these markers reduced the cell number required for thymic colonization. The HUCB cells used to colonize organ cultures have little immediate immune-response capacity against allogeneic and xenogeneic stimulation (14) , suggesting that the human T cells in these cultures probably did not arise from mature T cells that recognized mouse tissue. Finally, the immature T-cell intermediates detected in early HUCB/SCID cultures support the contention that the human T cells produced by these cultures were derived from immature T-cell precursors.
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Proc. Natl. Acad. Sci. USA 90 (1993) Other investigators (8, 9) have reported human T-cell development in murine dGuo FTOC. Development of human T cells in these systems depended upon the presence of an undefined high-density human thymic stromal element(s) (8) . In the present study, total cell recovery of human T cells significantly increased when untreated SCID or normal fetal thymus lobes were substituted for dGuo-treated tissue. Cell numbers from dGuo recipients colonized with human thymus-derived precursors, including the undefined thymic stromal elements (8) , resembled those obtained here with untreated tissue. Perhaps dGuo treatment is toxic for an important stromal-cell population in the thymus that is required for T-cell development. This cell type, or its precursor, may share some functions with the undefined human stromal elements required for the development of human T cells in earlier reports.
These same workers (8, 9) also found relatively high frequencies of human DP cells after 14-21 days of culture, a result suggesting that the mouse-human organ culture system can support human DP cell production. We found a transient and relatively lower frequency of DP cells. These cells arose faster (3-6 days of culture, with steady decreases up to 21 days of culture) than did the DP cells found by using thymic progenitor T cells (8, 9) . It is unlikely that these low numbers of DP cells are from enzymatic down-modulation of CD4 or CD8 during the cell-harvesting process because similarly treated mouse or human thymocytes have readily detectable DP cells (H.Y., D.T.H., and D.D., unpublished work). The low frequency and transient production of DP cells also suggest that organ-cultured progenitor T cells may develop into SP T cells without undergoing a DP developmental stage. This observation is compatible with studies using CD4 or CD8 "knockout" mice (18) , showing that murine thymocytes could differentiate into mature T cells without the coexpression of these markers. Perhaps the phenotypic differences in cell types supported by organ cultures using thymocytes, HBM, or HUCB as donor tissue result from qualitative differences in the progenitor T-cell populations used to seed the cultures. One difference may be a lack of the appropriate thymic stromal cell type(s) in murine FTOC. However, we recently found that cultures of human neonatal thymus have high initial numbers of DP cells at 5 days of FTOC, but 12 to 20 days of FTOC results in high numbers of CD4+ SP cells and low numbers of DP cells, suggesting that even normal human thymic stroma produce the phenotypes seen in the present study (H.Y., D.T.H., and D.D., unpublished work). Progenitor T-cell populations have been shown to differ qualitatively in proliferative capabilities and TCR gene usage (19, 20) . In addition, adult thymocyte precursors produce two to three times more peripheral CD4+ T cells than do fetal precursors (21) , an observation that may account for the skewed CD4/CD8 ratio of the organ cultured precursor cells seen here. Human dendritic cells derived from the same precursor as human T cells (as in mouse, ref. 22 ) may present human class II better than class I or human CD4 may interact better with mouse class II than human CD8 can interact with mouse class I. Indeed, Merkenschlager and Fisher (9) found that while blasts of DP and CD4+ cells could be found in their cultures, CD8+ blasts were undetectable.
Colony-forming assays (for granulocyte-macrophage and erythroid cells) have shown that the numbers of stem cells in HBM and HUCB are comparable and support the use of HUCB as a candidate for hematopoietic transplantation (10) . Titration experiments using HBM and HUCB described here showed that these tissues contained similar frequencies of cells that could colonize organ cultures. However, HPBLC also gave a frequency of T precursors similar to HBM and HUCB in the chimeric organ culture system, unlike colonyforming cell assays (10) . HPBLC may contain more precursors for T cells than precursors for other hematopoietic cells.
In conclusion, our results suggest that human T precursor cells can rapidly develop into large numbers of SP cells from readily obtainable tissues such as HBM, HUCB, and HP-BLC. Each source of precursors produced SP populations with different CD4/CD8 ratios, suggesting that precursor cells from different sources differ qualitatively in their capacities to differentiate into T cells.
